BK2220 Medical Distribution
- 2186.028
- +11.400+0.52%
Here's How Much $1000 Invested In Cencora 5 Years Ago Would Be Worth Today
Cencora (NYSE:COR) has outperformed the market over the past 5 years by 9.3% on an annualized basis producing an average annual return of 22.36%. Currently, Cencora has a market capitalization of $44.
Edap TMS Q1 2024 GAAP EPS €(0.12) Misses €(0.11) Estimate, Sales €14.908M Beat €14.877M Estimate
Edap TMS Q1 2024 GAAP EPS €(0.12) Misses €(0.11) Estimate, Sales €14.908M Beat €14.877M Estimate
Third Point Top Buy and Sells in Q1
Argus Research Maintains Buy on Cardinal Health, Lowers Price Target to $115
Argus Research analyst David Toung maintains Cardinal Health (NYSE:CAH) with a Buy and lowers the price target from $120 to $115.
Cardinal Health Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/15/2024 18.79% Argus Research $120 → $115 Maintains Buy 05/03/2024 18.79% Evercore ISI Group $110 → $11
Health Care Is Still Very Crowded but Trades at a Discount Vs. History - BofA
The health care sector (NYSEARCA:XLV) is crowded despite a reversal on the recession outlook, according to BofA Securities’ Sector Focus Point report.
Looking Into Henry Schein's Recent Short Interest
Henry Schein's (NYSE:HSIC) short percent of float has fallen 4.69% since its last report. The company recently reported that it has 5.24 million shares sold short, which is 4.67% of all regular shares
8 Out of 12 S&P 500 Healthcare Companies Beat Profit Consensus This Week: Earnings Scorecard
Dividend Roundup: Eli Lilly, American Express, Microsoft, Delta Air Lines, and More
10 Health Care Stocks With Whale Alerts In Today's Session
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth.
Barclays Maintains Overweight on McKesson, Raises Price Target to $596
Barclays analyst Steve Valiquette maintains McKesson (NYSE:MCK) with a Overweight and raises the price target from $571 to $596.
Barrington Research Maintains Outperform on Henry Schein, Raises Price Target to $92
Barrington Research analyst Michael Petusky maintains Henry Schein (NASDAQ:HSIC) with a Outperform and raises the price target from $90 to $92.
TD Cowen Maintains Buy on McKesson, Raises Price Target to $652
TD Cowen analyst Charles Ryhee maintains McKesson (NYSE:MCK) with a Buy and raises the price target from $563 to $652.
Evercore ISI Group Maintains Outperform on McKesson, Raises Price Target to $600
Evercore ISI Group analyst Elizabeth Anderson maintains McKesson (NYSE:MCK) with a Outperform and raises the price target from $590 to $600.
McKesson Hits New All-time High as Fiscal 2025 Outlook Pleases Street
UBS Maintains Neutral on Henry Schein, Lowers Price Target to $80
UBS analyst Kevin Caliendo maintains Henry Schein (NASDAQ:HSIC) with a Neutral and lowers the price target from $82 to $80.
Henry Schein Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/08/2024 12.44% UBS $82 → $80 Maintains Neutral 03/06/2024 23.68% JP Morgan $82 → $88 Maintains Overweig
These Analysts Increase Their Forecasts On McKesson Following Q4 Results
McKesson Corporation (NYSE:MCK) posted weaker-than-expected results for its fourth quarter on Tuesday.McKesson posted adjusted earnings of $6.18 per share, missing market expectations of $6.34 per sha
UBS Maintains Buy on McKesson, Raises Price Target to $630
UBS analyst Kevin Caliendo maintains McKesson (NYSE:MCK) with a Buy and raises the price target from $620 to $630.
Datadog To Rally Around 25%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.Piper Sandl